Association between clinical use of lansoprazole and the risk of type 2 diabetes mellitus: a pharmacoepidemiological cohort study

Abstract Background Proton pump inhibitors (PPIs) are common and widely used for gastrointestinal-related disorders. Lansoprazole is one of PPIs with potential benefits of anti-inflammation, reduced oxidative stress, and anti-diabetes. The aims of this study are to determine whether lansoprazole imp...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ming-Hsun Lin, Wen‐Tung Wu, Yong-Chen Chen, Tsung-Kun Lin, Yu‐Ching Chou, Chien‐An Sun
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2023-05-01
coleção:	Diabetology & Metabolic Syndrome
Assuntos:	Cohort studies Lansoprazole Proton pump inhibitors Type 2 diabetes mellitus
Acesso em linha:	https://doi.org/10.1186/s13098-023-01051-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!